Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.
Anita A G A van de MunckhofErik LindgrenTimothy John KleinigThalia S FieldCharlotte CordonnierKatarzyna KrzywickaSven PoliMayte Sánchez van KammenAfshin Borhani-HaghighiRobin LemmensAdrian ScutelnicAlfonso CicconeThomas GattringerMatthias WittstockVanessa DizonnoAnnemie DevroyeAhmed ElkadyAlbrecht GüntherAlvaro CerveraAnnerose MengelBeng Lim Alvin ChewBrian H BuckCarla ZanferrariCarlos Garcia-EsperonChristian JacobiCristina SorianoDominik MichalskiZohreh ZamaniDylan BlacquiereElias JohanssonElisa Cuadrado GodiaFabrice VuillierFelix J BodeFrancois CaparrosFrank MaierGeorgios K TsivgoulisHans D KatzbergJiangang DuanJim BurrowJohann PelzJoshua MbrohJoyce OenJudith SchoutenJulian ZimmermannKarl NgKatia GaramboisMarco PetruzzellisMariana Carvalho DiasMasoud GhiasianMichele RomoliMiguel A MirandaMiriam WronskiMona SkjellandMostafa Almasi-DooghaeePauline CuisenierSeán MurphySerge TimsitShelagh B CouttsSilvia SchönenbergerSimon NagelSini HiltunenSophie ChattertonThomas CoxThorsten BartschVahid ShaygannejadZahra MirzaasgariSaskia MiddeldorpMarcel M LeviJohanna A Kremer HovingaKatarina JoodTurgut TatlisumakJukka PutaalaMirjam Rachel HeldnerMarcel ArnoldDiana Aguiar de SousaJose M FerroJonathan M Coutinhonull nullPublished in: Stroke (2022)
In contrast to the high mortality of CVT-VITT in the acute phase, mortality among patients who survived the initial hospitalization was low, new thrombotic events did not occur, and bleeding events were rare. Approximately 9 out of 10 CVT-VITT patients who survived the acute phase were functionally independent at follow-up.